About Cellular Vehicles
Cellular Vehicles is a Healthcare company based in San Mateo (United States) founded in 2021. Cell-based therapeutics for blood-based diseases are developed and delivered locally. Cellular Vehicles offers products and services including Process Automation Tools. Its focus areas include Life Sciences, Cell Therapy, Diversified and Drug Delivery. Its legal entity is Cellular Vehicles Inc. Its competitors include Tenaya Therapeutics, Athira Pharma and Orca Bio; 3 of its 3 listed competitors have raised funding.
Company details
Cellular Vehicles was founded in 2021 in San Mateo, United States, within the biotechnology sector. Cell-based therapeutics targeting blood-based diseases are developed. A device for localized delivery of these therapeutics is provided. Additionally, a research model is offered to assess cell therapy performance across factors including localization, visibility, functionality, engraftment, and persistence. Operations focus on advancing therapeutic applications in hematology.
- Headquarters San Mateo, United States
- SectorsHealthcare
- Email••••••••
- Website cellularvehicles.com
- Social LinkedIn X
- Legal Name Cellular Vehicles Inc.
- Latest Funding Round$294.54K (USD), Grant
Jun 2024
- Investors
Products & Services of Cellular Vehicles
Cellular Vehicles offers a comprehensive portfolio of products and services, including Process Automation Tools.
Automate processes to scale cell and gene therapy operations effectively.
Funding Insights of Cellular Vehicles
- Total Rounds 1
- Last Round Grant — $294,541
- First Round $294,541
(Jun 2024)
- Investors Count 1
All 1 funding rounds of Cellular Vehicles with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2024 | $294,541 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Cellular Vehicles
Cellular Vehicles has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Cellular Vehicles
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Cellular Vehicles
2 dated milestones of Cellular Vehicles across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Cellular Vehicles is founded.
- Funding First funding round of $295K.
Competitors of Cellular Vehicles
Cellular Vehicles has 3 listed competitors in our database, 3 of them funded. They include Tenaya Therapeutics, Athira Pharma and Orca Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tenayatherapeutics.com | 2016 | San Francisco, United States | $142M | 140 | Regenerative and gene therapeutics for heart failure are developed. | |
| athira.com | 2011 | Seattle, United States | $121.04M | 62 | Neurodegenerative disease therapeutics, including for Alzheimer’s and Parkinson’s, are developed. | |
| orcabio.com | 2016 | Menlo Park, United States | $300M | 66 | Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders |
Detailed competitors of Cellular Vehicles
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cell Therapy
3 companies that operate in the same segment as Cellular Vehicles (Cell Therapy) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 | ||
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cellular Vehicles
Cellular Vehicles was founded in 2021 and raised its 1st funding round 3 years after it was founded.
Cellular Vehicles is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
Cellular Vehicles was founded in 2021 in San Mateo, United States, within the biotechnology sector. Cell-based therapeutics targeting blood-based diseases are developed. A device for localized delivery of these therapeutics is provided. Additionally, a research model is offered to assess cell therapy performance across factors including localization, visibility, functionality, engraftment, and persistence. Operations focus on advancing therapeutic applications in hematology.
Cellular Vehicles's top competitors include Tenaya Therapeutics, Athira Pharma and Orca Bio.
Cellular Vehicles offers Process Automation Tools.
Cellular Vehicles has 1 investor. Key investors include HHS.
Cellular Vehicles operates through Cellular Vehicles Inc..